共 208 条
[31]
Aboulghar MA(2008)Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study Reprod Biomed Online 17 751-457
[32]
Mansour RT(2010)Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial J Assist Reprod Genet 29 259-3032
[33]
Serour GI(2010)Physiology andpathology of ovarian hyperstimulation syndrome Semin Reprod Med 28 448-54
[34]
Delvigne A(2002)Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review Hum Reprod 17 3027-90
[35]
Dubois M(2010)Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis Gynecol Obstet Invest 70 47-363
[36]
Battheu B(2011)Intravenous fluids for the prevention of severe ovarian hyperstimulation syndrome Cochrane Database Syst Rev 2 CD001302-988
[37]
Ragni G(2004)Reproductive biology and IVF: ovarian stimulation and endometrial receptivity Trends Endocrinol Metab 15 84-1213
[38]
Vegetti W(2006)The early luteal phase administration of oestrogen and progesterone does not induce premature luteolysis in normo-ovulatory women Eur J Endocrinol 155 355-1008
[39]
Riccaboni A(2007)Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial Hum Reprod 22 980-1792
[40]
Engl B(1996)The effect of human menopausal gonadotropin and highly purified, urine-derived follicle stimulating hormone on the outcome of in vitro fertilisation in down regulated normogonadotropic women Hum Reprod 11 1209-2340